- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Invesco NASDAQ Biotech UCITS ETF (SBIO)
Find here information about the Invesco NASDAQ Biotech ETF, assess the current SBIO stock price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. (ISIN: IE00BQ70R696)
41.04
-0.02(-0.05%)
Closed·
Day's Range
40.65
41.04
52 wk Range
37.44
51.23
Invesco NASDAQ Biotech UCITS ETF
41.04
-0.02(-0.05%)
(right-click to deleteright-click to manage)(long-press to drag)(drag to change anchor time)
SPY
Day's Range
40.6541.04
52 wk Range
37.4451.23
- Bid/Ask
- 35.00 / 52.00
- Prev. Close
- 41.04
- Price Open
- 40.67
- Volume
- 6,719
- Average Volume (3m)
- 6,662
- 1-Year Change
- -10.73%
- Day's Range
- 40.65-41.04
- 52 wk Range
- 37.44-51.23
- Market Cap
- 242.31M
How do you feel today about SBIO?
Vote to see community's results!
orPerformance
Invesco NASDAQ Biotech UCITS ETF Company Profile
Invesco Markets Plc - Invesco NASDAQ Biotech UCITS ETF is an exchange traded fund launched by Source Investment Management Limited. The fund is managed by Assenagon Asset Management S.A. It invests in the public equity markets across the globe. The fund uses derivatives such as swaps to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sectors. It invests in the stocks of companies across all market capitalizations, with a minimum market capitalization of US $200 million. The fund seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing synthetic replication methodology. Invesco Markets Plc - Invesco NASDAQ Biotech UCITS ETF was formed on November 6, 2014 and is domiciled in Ireland.
FAQ
How is the performance of SBIO?
As of May 16, 2025, SBIO is trading at a price of 41.04, with a previous close of 41.04. The stock has fluctuated within a day range of 40.65 to 41.04, while its 52-week range spans from 37.44 to 51.23.
What is the current price of SBIO?
The SBIO stock price today is 41.04.
What is the P/E ratio of SBIO?
The P/E ratio for SBIO is 14.34.
From a Technical Analysis Perspective, Is SBIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What is the SBIO market cap?
The market cap for SBIO is 242.31M.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.